非布索坦
医学
痛风
别嘌呤醇
卡那努马布
高尿酸血症
重症监护医学
内科学
尿酸
阿纳基纳
疾病
作者
Lisa K. Stamp,Nicola Dalbeth
标识
DOI：10.1038/s41584-018-0149-7
摘要
In 2018, advances in the treatment of gout flares came in the form of a new nurse-led management approach to serum urate lowering and evidence that allopurinol might have a better cardiovascular safety profile than febuxostat. However, are IL-1β blockers such as canakinumab the future of care for patients with gout?
科研通智能强力驱动
Strongly Powered by AbleSci AI
cdercder
冰魂
pluto
SYLH
不倦
文献看不懂
昏睡的蟠桃
eee
bc
剑指东方是为谁
科研助手6
wy.he
归尘
科研小民工
遇上就这样吧
qiao
YifanWang
一一
8R60d8
iNk
皖公网安备34019202002308
